Comparison of Canagliflozin vs. Alternative Antihyperglycemic Treatments on Risk of Below Knee Lower Extremity Amputation for Patients with Type 2 Diabetes Mellitus and the Subpopulation with Established Cardiovascular Disease First published 24/01/2019 Last updated 27/03/2020 EU PAS number:EUPAS27670 Study Finalised